Catalysts for a healthier planet

About Us

Our modern lives are destroying the planet we call home. Creating a positive future requires unprecedented vision, bold action and better solutions. Epoch is combining unique insights from nature with deep expertise in computational and biological sciences to develop enzymes to unlock applications previously deemed impossible. At Epoch, scientists who have spent their entire careers working on these solutions have come together with fresh graduates to build breakthrough approaches to designing and scaling biology. 

Inside Epoch

Our passion is real

We come to work every day, knowing that we will have a significant positive impact on our planet. Our motivation comes from our mission and our people: clever, spirited, opinionated, authentic personalities that we learn from and have fun with!

Selected Investors

Meet The Team

Jacob Nathan

Jacob Nathan

Co-founder, CEO

Prof Doug Kell, CBE

Prof Doug Kell, CBE

Co-founder, CSO

Beatriz Lopez

Beatriz Lopez

CPO

Soumik Basu, PhD

Soumik Basu, PhD

Synthetic Biologist

Vittorio Bartoli, PhD

Vittorio Bartoli, PhD

Scientist

Charlotte Gruender, PhD

Charlotte Gruender, PhD

BD Analyst

Rachel Heath, PhD

Rachel Heath, PhD

Senior Scientist

James Johnson, PhD

James Johnson, PhD

Director of Enzyme Engineering

Giorgio Lai, PhD

Giorgio Lai, PhD

Scientist

Angela Sims, PhD

Angela Sims, PhD

Lab Manager

Neil Swainston, PhD

Neil Swainston, PhD

Director of Computational Biology

Mike Winn, PhD

Mike Winn, PhD

Scientist